Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.
The oncoprotein and transcriptional regulator bcl-3 governs plasticity and pathogenicity of autoimmune T cells.
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Generalised cognitive motor interference in multiple sclerosis.
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
Immune-mediated processes in neurodegeneration: where do we stand?
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Sexual dimorphism in the aged rat CD4+ T lymphocyte-mediated immune response elicited by inoculation with spinal cord homogenate.
Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
Restless legs syndrome in multiple sclerosis.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis.
Clutter management for individuals with multiple sclerosis.
Benign neuromyelitis optica is rare in Japanese patients.
Neuroinflammation: Transport disruption in multiple sclerosis.
Pages
« first
‹ previous
…
522
523
524
525
526
527
528
529
530
…
next ›
last »